Ayurcann Holdings Corp. reported earnings results for the full year ended June 30, 2022. For the full year, the company reported revenue was CAD 9.39 million compared to CAD 7.63 million a year ago.

Net loss was CAD 3.09 million compared to CAD 0.27836 million a year ago. Basic loss per share from continuing operations was CAD 0.027 compared to CAD 0.003 a year ago.